Source: Annual Congress 2008 - Pulmonary arterial hypertension and other pulmonary vascular diseases
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
S. van Eijl, G. P. Diller, D. O. Okonko, L. S. Howard, O. Ali, T. Thum, S. J. Wort, E. Bédard, J. S. R. Gibbs, J. Bauersachs, A. J. Hobbs, M. R. Wilkins, M. A. Gatzoulis, J. Wharton (London, United Kingdom; Würzburg, Germany). Circulating endothelial progenitor cells in patients with Eisenmenger syndrome and idiopathic pulmonary arterial hypertension. Eur Respir J 2008; 32: Suppl. 52, 1430

Member's Comments

No comment yet.

Related content which might interest you: Circulating angiopoietins in idiopathic pulmonary arterial hypertension Source: Annual Congress 2010 - Pulmonary hypertension Year: 2010 Circulating endothelial progenitor cells and chronic pulmonary diseases Source: Eur Respir J 2011; 37: 426 Year: 2011 Circulating fibrocytes in pulmonary arterial hypertension Source: Annual Congress 2011 - Clinical characteristics of patients with pulmonary hypertension Year: 2011 Circulating fibrocytes and pulmonary arterial hypertension Source: Eur Respir J 2011; 39: 210-212 Year: 2012 Circulating fibrocytes and pulmonary arterial hypertension Source: Eur Respir J 2012; 39: 210-212 Year: 2012 Dysregulation of iron homeostasis in Eisenmenger syndrome; comparison to idiopathic pulmonary arterial hypertension and healthy controls Source: International Congress 2016 – Pulmonary hypertension: the clinic I Year: 2016 Circulating endothelial progenitor cells in COPD: effect of pulmonary hypertension Source: Annual Congress 2007 - Cellular and molecular aspects of pulmonary hypertension Year: 2007 Endothelial progenitor cells in patients with chronic obstructive pulmonary disease Source: Annual Congress 2008 - Regulatory mechanisms of cell activation, renewal and recruitment Year: 2008 Imbalance between circulating endothelial cells and endothelial progenitors in idiopathic pulmonary fibrosis Source: Annual Congress 2011 - What is new in the approach to pulmonary fibrosis? Year: 2011 Circulating endothelial progenitor cells in patients with idiopathic pulmonary fibrosis (preliminary results) Source: Annual Congress 2008 - Management of idiopathic pulmonary fibrosis: what can we learn from the pathophysiology? Year: 2008 Endothelial progenitor cells in chronic thromboembolic pulmonary hypertension Source: International Congress 2018 – Chronic thromboembolic pulmonary hypertension Year: 2018 Endothelial cells in the pathogenesis of pulmonary arterial hypertension Source: Eur Respir J, 58 (3) 2003957; 10.1183/13993003.03957-2020 Year: 2021 Increased stimulatory capacities of dendritic cells in idiopathic pulmonary arterial hypertension Source: Annual Congress 2010 - Pathobiology of pulmonary hypertension Year: 2010 Dysfunctional endothelial cells in patients with chronic thromboembolic pulmonary hypertension Source: International Congress 2017 – Experimental PH Year: 2017 Comparison of exercise capacity, pulmonary functions, respiratory and peripheral muscle strength between patients with idiopathic pulmonary arterial hypertension and Eisenmenger syndrome Source: Annual Congress 2012 - Assessment of physical activity, exercise, muscle function and clinical characteristics as outcomes in physiotherapy and rehabilitation Year: 2012 Pulmonary arterial hypertension in scleroderma – manifestation of systemic endothelial dysfunction Source: Eur Respir J 2006; 28: Suppl. 50, 548s Year: 2006 Pulmonary hypertension and endothelial dysfunction in patients with COPD Source: Eur Respir J 2007; 30: Suppl. 51, 605s Year: 2007 Features of endothelial dysfunction in patients with COPD in combination with arterial hypertension Source: Eur Respir J 2007; 30: Suppl. 51, 768s Year: 2007 Treprostinil inhibits the recruitment of bone marrow-derived circulating fibrocytes in chronic hypoxic pulmonary hypertension Source: Eur Respir J 2010; 36: 1302-1314 Year: 2010 Systemic endothelial dysfunction in patients and first order relatives with pulmonary arterial hypertension Source: Annual Congress 2004 - Pulmonary hypertension Year: 2004